ML17362A083: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
Line 19: Line 19:


=Text=
=Text=
{{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 January 9, 2018 Dr. Gregory Piefer  
{{#Wiki_filter:UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 January 9, 2018 Dr. Gregory Piefer Chief Executive Officer Shine Medical Technologies 2555 Industrial Drive Monona, WI 53713
 
Chief Executive Officer Shine Medical Technologies 2555 Industrial Drive Monona, WI 53713  


==SUBJECT:==
==SUBJECT:==
SHINE MEDICAL TECHNOLOGIES - REGULATORY INFORMATION     CONFERENCE 2018 INVITATION LETTER, SPEAKER CONFIRMATION   FORM, AND EXTERNAL AGREEMENT FORM (CAC MF1395)  
SHINE MEDICAL TECHNOLOGIES - REGULATORY INFORMATION CONFERENCE 2018 INVITATION LETTER, SPEAKER CONFIRMATION FORM, AND EXTERNAL AGREEMENT FORM (CAC MF1395)


==Dear Dr. Piefer:==
==Dear Dr. Piefer:==


It is my pleasure to invite you to participate as a speaker at NRC's 30 th Regulatory Information Conference (RIC). The RIC will be held on March 13-15, 2018, at the Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.  
It is my pleasure to invite you to participate as a speaker at NRCs 30th Regulatory Information Conference (RIC). The RIC will be held on March 13-15, 2018, at the Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.
 
This 3-day annual conference is co-sponsored by the Office of Nuclear Reactor Regulation and the Office of Nuclear Regulatory Research, and brings together more than 3,000 participants from over 30 countries representing interested parties from government, industry, international agencies, other interested stakeholders, and members of the public. The RIC fosters communication about U.S. Nuclear Regulatory Commission (NRC) activities, and offers a valuable forum to share perspectives on technical issues and other matters facing the nuclear industry.
This 3-day annual conference is co-sponsored by the Office of Nuclear Reactor Regulation and the Office of Nuclear Regulatory Research, and brings together more than 3,000 participants from over 30 countries representing interested parties from government, industry, international agencies, other interested stakeholders, and members of the public. The RIC fosters communication about U.S. Nuclear Regulatory Commission (NRC) activities, and offers a valuable forum to share perspectives on technical issues and other matters facing the nuclear  
Your participation as a technical session panelist will bring great value to our session entitled, Progress Toward a Reliable Domestic Supply of Molybdenum-99 [Mo-99], which I will be chairing. The session will be held on Wednesday, March 14, 2018, from 1:30 p.m. to 3:00 p.m.
 
We would like to give participants an opportunity to learn, What improvements are underway in construction inspection procedures, operation inspection procedures, guidance, and considerations of the impact of proposed rulemakings, on potential medical isotope facilities? This session details the progress toward licensing and regulating medical isotope facilities and shares the perspectives of regulators, licensee, the Department of Energy, and other stakeholders. I am anticipating that you can speak about recent SHINE activities addressing the future domestic production of Mo-99.
industry.
Your participation as a technical session panelist will bring great value to our session entitled , "Progress Toward a Reliable Domestic Supply of Molybdenum-99 [Mo-99]
," which I will be chairing. The session will be held on Wednesday, March 14, 2018, from 1:30 p.m. to 3:00 p.m.
We would like to give participants an opportunity to learn, "What improvements are underway in construction inspection procedures, operation inspection procedures, guidance, and considerations of the impact of proposed rulemakings, on potential medical isotope facilities?"  This session details the progress toward licensing and regulating medical isotope facilities and shares the perspectives of regulators, licensee, the Department of Energy, and other stakeholders. I am anticipating that you can speak about recent SHINE activities addressing the future domestic production of Mo-99.
I hope you are able to accept this invitation. You can find RIC-related news and up-to-date conference information by navigating from the NRC's official public website at http://www.nrc.gov. To confirm your participation, please complete and return the enclosed  RIC Speaker Confirmation Form and RIC External Speaker Agreement Form to  Ms. Cindy Montgomery, our session coordinator, by January 16, 2018. Please contact Ms. Montgomery or me if you have questions. Ms. Montgomery can be reached on 301-415-3398 or Cindy.Montgomery@nrc.gov. Sincerely,           
/RA Linh Tran for/
Alexander Adams, Jr., Chief Research and Test Reactors Licensing Branch  Division of Licensing Projects  Office of Nuclear Reactor Regulation


Docket No. 50-608  
I hope you are able to accept this invitation. You can find RIC-related news and up-to-date conference information by navigating from the NRCs official public website at http://www.nrc.gov. To confirm your participation, please complete and return the enclosed RIC Speaker Confirmation Form and RIC External Speaker Agreement Form to Ms. Cindy Montgomery, our session coordinator, by January 16, 2018. Please contact Ms. Montgomery or me if you have questions. Ms. Montgomery can be reached on 301-415-3398 or Cindy.Montgomery@nrc.gov.
Sincerely,
                                                /RA Linh Tran for/
Alexander Adams, Jr., Chief Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-608


==Enclosures:==
==Enclosures:==


RIC Speaker Confirmation Form  
RIC Speaker Confirmation Form RIC External Speaker Agreement Form
 
RIC External Speaker Agreement Form  


ML17362A083,Letter; ML17355A548 / ML17355A550 Forms; ML17362A105 -Pkg. *concurred via email                         NRR-088 OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/BC NRR/DLP/PRLB/PM NAME CMontgomery AAdams (LTran for) CMontgomery DATE 12/27/2017 1/9/2017 1/9/2017}}
ML17362A083,Letter; ML17355A548 / ML17355A550 Forms; ML17362A105 -Pkg. *concurred via email                             NRR-088 OFFICE     NRR/DLP/PRLB/PM       NRR/DLP/PRLB/BC     NRR/DLP/PRLB/PM NAME       CMontgomery           AAdams             CMontgomery (LTran for)
DATE       12/27/2017             1/9/2017           1/9/2017}}

Latest revision as of 06:43, 22 October 2019

RIC Invitation Letter External Speaker & Forms - 2018 Piefer
ML17362A083
Person / Time
Site: SHINE Medical Technologies
Issue date: 01/09/2018
From: Alexander Adams
Research and Test Reactors Licensing Projects Branch
To: Piefer G
SHINE Medical Technologies
Montgomery C, NRR/DLP, 415-3398
Shared Package
ML17362A105 -Pkg. List:
References
CAC MF1395
Download: ML17362A083 (3)
v • d • e


Text

UNITED STATES NUCLEAR REGULATORY COMMISSION WASHINGTON, D.C. 20555-0001 January 9, 2018 Dr. Gregory Piefer Chief Executive Officer Shine Medical Technologies 2555 Industrial Drive Monona, WI 53713

SUBJECT:

SHINE MEDICAL TECHNOLOGIES - REGULATORY INFORMATION CONFERENCE 2018 INVITATION LETTER, SPEAKER CONFIRMATION FORM, AND EXTERNAL AGREEMENT FORM (CAC MF1395)

Dear Dr. Piefer:

It is my pleasure to invite you to participate as a speaker at NRCs 30th Regulatory Information Conference (RIC). The RIC will be held on March 13-15, 2018, at the Bethesda North Marriott Hotel and Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852.

This 3-day annual conference is co-sponsored by the Office of Nuclear Reactor Regulation and the Office of Nuclear Regulatory Research, and brings together more than 3,000 participants from over 30 countries representing interested parties from government, industry, international agencies, other interested stakeholders, and members of the public. The RIC fosters communication about U.S. Nuclear Regulatory Commission (NRC) activities, and offers a valuable forum to share perspectives on technical issues and other matters facing the nuclear industry.

Your participation as a technical session panelist will bring great value to our session entitled, Progress Toward a Reliable Domestic Supply of Molybdenum-99 [Mo-99], which I will be chairing. The session will be held on Wednesday, March 14, 2018, from 1:30 p.m. to 3:00 p.m.

We would like to give participants an opportunity to learn, What improvements are underway in construction inspection procedures, operation inspection procedures, guidance, and considerations of the impact of proposed rulemakings, on potential medical isotope facilities? This session details the progress toward licensing and regulating medical isotope facilities and shares the perspectives of regulators, licensee, the Department of Energy, and other stakeholders. I am anticipating that you can speak about recent SHINE activities addressing the future domestic production of Mo-99.

I hope you are able to accept this invitation. You can find RIC-related news and up-to-date conference information by navigating from the NRCs official public website at http://www.nrc.gov. To confirm your participation, please complete and return the enclosed RIC Speaker Confirmation Form and RIC External Speaker Agreement Form to Ms. Cindy Montgomery, our session coordinator, by January 16, 2018. Please contact Ms. Montgomery or me if you have questions. Ms. Montgomery can be reached on 301-415-3398 or Cindy.Montgomery@nrc.gov.

Sincerely,

/RA Linh Tran for/

Alexander Adams, Jr., Chief Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-608

Enclosures:

RIC Speaker Confirmation Form RIC External Speaker Agreement Form

ML17362A083,Letter; ML17355A548 / ML17355A550 Forms; ML17362A105 -Pkg. *concurred via email NRR-088 OFFICE NRR/DLP/PRLB/PM NRR/DLP/PRLB/BC NRR/DLP/PRLB/PM NAME CMontgomery AAdams CMontgomery (LTran for)

DATE 12/27/2017 1/9/2017 1/9/2017

Retrieved from "https://kanterella.com/w/index.php?title=ML17362A083&oldid=1961690"